Real-World Effectiveness of RSVpreF and RSVpreF3 Vaccines in Preventing Hospitalization and Emergency Department Visits Associated With Respiratory Syncytial Virus in Older Adults: A Meta-analysis
Clinical Infectious Diseases · 2026
DOI: 10.1093/cid/ciag107 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Dewan Md Sumsuzzman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Agent-Based Modelling Laboratory, Centre of Excellence in AI for Public Health Advancement, York University, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Vaccines, Hospitalization, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Ontario Research Fund-Research Excellence, Ontario Research Fund–Research Excellence.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Respiratory syncytial virus (RSV) vaccines were first recommended for older adults during the 2023–2024 season in countries that authorized their use. Although early observational studies complemented trial findings, real-world evidence on vaccine effectiveness against severe RSV disease remains limited. We assessed the effectiveness of RSVpreF and RSVpreF3 vaccines in preventing RSV-related hospitalizations and emergency department (ED) visits among older adults.
Methods
We searched MEDLINE, Embase, Web of Science, Scopus, Global Health, and medRxiv for observational studies published between 1 January 2023 and 30 December 2025, reporting real-world effectiveness of RSV vaccines in adults aged 60 years or older. Pooled analyses used inverse-variance random-effects models to estimate effectiveness against RSV-related hospitalizations and ED visits. Subgroup analyses assessed differences in effectiveness by age, immune status, and vaccine type. This study is registered with PROSPERO (CRD420251021777).
Results
From 4925 records screened, 8 cohort and case-control studies were included. Vaccination was associated with lower odds of RSV-related hospitalization (odds ratio [OR]: 0.23; 95% confidence interval [CI], 0.20–0.27; I² = 6.5%) and ED visits (OR: 0.23; 95% CI, 0.21–0.27; I² = 0.0%). Effectiveness against RSV-related hospitalization was lower in immunocompromised adults (OR: 0.31; 95% CI, 0.27–0.34; I² = 0.0%) than in immunocompetent individuals (OR: 0.20; 95% CI, 0.11–0.35; I² = 0.0%). Effectiveness did not differ by age group (60–74 vs ≥75 years) or vaccine product.
Conclusions
Vaccination provided substantial protection against RSV-related healthcare utilization among older adults. Continued surveillance and real-world evidence are needed to inform immunization policy and improve protection in immunocompromised individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Agent-Based Modelling Laboratory, Centre of Excellence in AI for Public Health Advancement, York University, Toronto, ON, Canada.
- Laboratory for Industrial and Applied Mathematics, York University, Toronto, ON, Canada.
- National Laboratory for Health Security, University of Szeged, Szeged, Hungary.
ORCID-Profile: Dewan Md Sumsuzzman, Congjie Shi, Seyed M Moghadas
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Ontario Research Fund-Research Excellence
- Ontario Research Fund–Research Excellence
Zitieren
APA
Sumsuzzman, D. M., Shi, C., & Moghadas, S. M. (2026). Real-World Effectiveness of RSVpreF and RSVpreF3 Vaccines in Preventing Hospitalization and Emergency Department Visits Associated With Respiratory Syncytial Virus in Older Adults: A Meta-analysis. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag107
Vancouver
Sumsuzzman DM, Shi C, Moghadas SM. Real-World Effectiveness of RSVpreF and RSVpreF3 Vaccines in Preventing Hospitalization and Emergency Department Visits Associated With Respiratory Syncytial Virus in Older Adults: A Meta-analysis. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag107
BibTeX
@article{Sumsuzzman2026,
author = {Sumsuzzman, Dewan Md and Shi, Congjie and Moghadas, Seyed M},
title = {Real-World Effectiveness of RSVpreF and RSVpreF3 Vaccines in Preventing Hospitalization and Emergency Department Visits Associated With Respiratory Syncytial Virus in Older Adults: A Meta-analysis},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciag107}
}
EUVIMED